logo

STOK

Stoke Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

STOK fundamentals

Stoke Therapeutics (STOK) released its earnings on Nov 4, 2025: revenue was 10.63M (YoY +117.20%), beat estimates; EPS was -0.65 (YoY -38.30%), missed estimates.
Revenue / YoY
10.63M
+117.20%
EPS / YoY
-0.65
-38.30%
Report date
Nov 4, 2025
STOK Earnings Call Summary for Q3,2025
  • Phase 3 Momentum: Over 200 patients pre-screened for Emperor, with 20 randomized, targeting H2 2026 enrollment completion.
  • FDA Engagement: Multidisciplinary meeting highlights potential expedited pathways, leveraging 4-year data showing 80% seizure reduction and VABS-III improvements.
  • Financial Strength: $328.6M cash runway, 126% YoY revenue growth, and $48.7M ATM raise support long-term growth.
  • Pipeline Innovation: ADOA shows functional vision recovery in preclinical models; SYNGAP1 advancing with CNS platform validation.
EPS
Revenue

Revenue & Expenses

STOK has released its 2025 Q3 earnings report, with revenue of 10.63M, reflecting a YoY change of 117.25%, and net profit of -38.35M, showing a YoY change of -45.09%. The Sankey diagram below clearly presents STOK's revenue sources and cost distribution.

Key Indicators

Stoke Therapeutics (STOK) key financial stats and ratios, covering profitability, financial health, and leverage.
Stoke Therapeutics (STOK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Stoke Therapeutics (STOK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Stoke Therapeutics (STOK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Stoke Therapeutics (STOK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Stoke Therapeutics (STOK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield